Aeterna Zentaris receives $2.5M net product sales milestone payment from Cowen Royalty Aeterna Zentaris Inc.P. . Related StoriesLilly expands existing immuno-oncology collaboration with AstraZenecaNew guidance statement on palliative treatment to be provided at 2015 Palliative Treatment in Oncology SymposiumResearchers find that 26 percent of senior oncology patients make use of complementary or substitute medicinesJuergen Engel, Ph.D., President and CEO of Aeterna Zentaris stated, We are very happy to reach this $2.5 million milestone which will be incremental to progress perifosine, AEZS-108 and other innovative oncology compounds from our extensive product pipeline. .It was predicated on interviews with 5,092 adults in 2001 and 2002. Olfson said it took time to investigate the data, including weighting the total results to extrapolate national numbers. Today However the authors said the outcomes may possibly hold true. The analysis was funded with grants from the Nationwide Institutes of Health, the American Base for Suicide Prevention and the brand new York Psychiatric Institute.